Source: Guideline 2011



Rating:

Share or cite this content

Citations should be made in the following way:
W.J. Randerath, J. Verbraecken, S. Andreas, et al.. Non-CPAP therapies in obstructive sleep apnoea. Guideline 2011

Member's Comments

No comment yet.

Related content which might interest you: Ato-oxy as the first successful pharmacotherapy for obstructive sleep apnoea Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside Year: 2019 Efficacy of a FOT-based auto-CPAP device for the treatment of obstructive sleep apnea Source: International Congress 2018 – New diagnostic tools for sleep and breathing and healthcare provision options Year: 2018 The velumount device for obstructive sleep apnoea Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea Year: 2009 Comparison of 2 auto-CPAP devices for treatment of obstructive sleep apnoea Source: Eur Respir J 2002; 20: Suppl. 38, 101s Year: 2002 AutoCPAP devices accurately identify obstructive sleep apnea patients with residual apnea during treatment Source: Annual Congress 2011 - Obstructive sleep apnoea : physiology, diagnostic tools and technology Year: 2011 ACE-inhibitors and obstructive sleep apnoea Source: Eur Respir J 2005; 26: Suppl. 49, 358s Year: 2005 Daytime hypoxemia in obstructive sleep apnoea (OSA) subjects before CPAP therapy Source: Annual Congress 2009 - Clinical aspects of sleep apnoea Year: 2009 The role of bi-level therapy in obstructive sleep apnoea Source: Annual Congress 2008 - Innovative treatments in sleep disordered breathing Year: 2008 Change in PLMS after treatment of obstructive sleep apnea Source: Eur Respir J 2007; 30: Suppl. 51, 593s Year: 2007 Possibility of treating patients with obstructive sleep apnea syndrome and nocturnal asystoles using CPAP therapy Source: Annual Congress 2009 - Clinical aspects of sleep apnoea Year: 2009 Oxygen for the treatment of obstructive sleep apnoea hypopnoea syndrome Source: Breathe, 15 (3) e104; 10.1183/20734735.0206-2019 Year: 2019 Return of sleep apnoea and sleep fragmentation following CPAP withdrawal in patients with obstructive sleep apnoea Source: Eur Respir J, 53 (5) 1802351; 10.1183/13993003.02351-2018 Year: 2019 Targeted hypoglossal neurostimulation for obstructive sleep apnoea: a 1-year pilot study Source: Eur Respir J 2013; 41: 360-367 Year: 2013 Does auto-CPAP improve the quality of sleep in obstructive sleep apnoea (OSA)? Source: Eur Respir J 2001; 18: Suppl. 33, 418s Year: 2001 Hypercapnia and respiratory drive in obstructive sleep apnoea patients before and after CPAP treatment Source: Eur Respir J 2002; 20: Suppl. 38, 103s Year: 2002 Prevalence of complex sleep apnea (CompSAS) during manual CPAP titration for obstructive sleep apnea Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009 Hypertension and obstructive sleep apnoea Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006 Role of CPAP treatment in elderly with moderate obstructive sleep apnea Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019 Clinical assessment of obstructive sleep apnoea Source: Annual Congress 2006 - PG9 - Obstructive sleep apnoea: current pathophysiological, clinical and therapeutic concepts Year: 2006 Compliance with CPAP/BiPAP treatment in obstructive sleep apnea syndrome patients Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010